Darkfield microscopy |
Urine |
Leptospira organisms |
Low sensitivity and specificity. Requires considerable technical expertise to interpret correctly. |
Culture |
Whole blood, urine |
Leptospires |
Special media required. Although sensitivity has historically been considered low and prolonged incubation times have been required, recent improvements in media have been associated with increased yields and shorter incubation times. |
Microscopic agglutination test |
Serum |
Antibodies against various leptospiral serovars |
False negatives can occur early in the course of illness or with immunosuppression, or when panels are used with limited numbers of serovars. False positives can occur with a history of vaccination in animals or with previous exposure. Paired titers performed at the same laboratory generally required for diagnosis. Inter-laboratory variation in results may occur. |
Rapid diagnostic chromatographic or ELISA based tests |
Serum or plasma |
IgM or IgG against Leptospira
|
False negatives can occur early in the course of illness or with immunosuppression. False positives can occur with a history of vaccination in animals or with previous exposure. Weak positive results can be difficult to read. No information in infecting serogroup. |
Histopathology |
Kidney tissue collected via biopsy or necropsy |
Leptospires |
Organisms may be visualized with silver stains, immunohistochemistry, or fluorescence in situ hybridization. Antimicrobial therapy may lead to false-negative results. |
Nucleic acid amplification tests |
Blood, urine, CSF, tissue specimens |
Leptospira DNA |
Sensitivity and specificity unclear and may vary between assays offered by different laboratories. Antimicrobial therapy may lead to negative results. A positive result from a urine specimen may not have etiologic predictive value because of the potential for subclinical carriage. |